Cargando…

Evaluation of K18-hACE2 Mice as a Model of SARS-CoV-2 Infection

Murine models of SARS-CoV-2 infection are critical for elucidating the biological pathways underlying COVID-19. Because human angiotensin-converting enzyme 2 (ACE2) is the receptor for SARS-CoV-2, mice expressing the human ACE2 gene have shown promise as a potential model for COVID-19. Five mice fro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moreau, Gregory Brett, Burgess, Stacey L., Sturek, Jeffrey M., Donlan, Alexandra N., Petri, William A., Mann, Barbara J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Tropical Medicine and Hygiene 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470527/ https://www.ncbi.nlm.nih.gov/pubmed/32723427 http://dx.doi.org/10.4269/ajtmh.20-0762

Ejemplares similares

Improved survival of SARS COV-2-infected K18-hACE2 mice treated with adenosine A(2A)R agonist()
por: Mann, Barbara J., et al.
Publicado: (2023)

Fatal Neurodissemination and SARS-CoV-2 Tropism in K18-hACE2 Mice Is Only Partially Dependent on hACE2 Expression
por: Carossino, Mariano, et al.
Publicado: (2022)

Neuroinvasion and Neurotropism by SARS-CoV-2 Variants in the K18-hACE2 Mouse
por: Seehusen, Frauke, et al.
Publicado: (2022)

Comparative pathology of the nasal epithelium in K18-hACE2 Tg mice, hACE2 Tg mice, and hamsters infected with SARS-CoV-2
por: Yu, Pin, et al.
Publicado: (2022)

Protocol for infecting and monitoring susceptible k18-hACE2 mice with SARS-CoV-2
por: Couto, Joana, et al.
Publicado: (2023)

Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice
por: Kumari, Pratima, et al.
Publicado: (2021)

Impact of Microbiota Depletion by Antibiotics on SARS-CoV-2 Infection of K18-hACE2 Mice
por: Rodrigues, Patrícia Brito, et al.
Publicado: (2022)

In Vivo protection from SARS-CoV-2 infection by ATN-161 in k18-hACE2 transgenic mice
por: Amruta, Narayanappa, et al.
Publicado: (2021)

Prolonged Protective Immunity Induced by Mild SARS-CoV-2 Infection of K18-hACE2 Mice
por: Bar-On, Liat, et al.
Publicado: (2022)

An S1-Nanoparticle Vaccine Protects against SARS-CoV-2 Challenge in K18-hACE2 Mice
por: van Oosten, Linda, et al.
Publicado: (2022)

K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research
por: Dedoni, Simona, et al.
Publicado: (2022)

SARS-CoV-2 Delta variant induces enhanced pathology and inflammatory responses in K18-hACE2 mice
por: Lee, Katherine S., et al.
Publicado: (2022)

Sex-Specific Differences in the Pathogenesis, Endothelial Dysfunction, and Hypercoagulability of Sars-Cov-2 Infection in K18-hACE2 Mice
por: Aiolfi, Roberto, et al.
Publicado: (2022)

Comparison of the pathogenesis of SARS-CoV-2 infection in K18-hACE2 mouse and Syrian golden hamster models
por: Jeong, Haengdueng, et al.
Publicado: (2022)

Therapeutic Effect of C-Vx Substance in K18-hACE2 Transgenic Mice Infected with SARS-CoV-2
por: Ulbegi Polat, Hivda, et al.
Publicado: (2023)

COVID-19 Treatments and Pathogenesis Including Anosmia in K18-hACE2 mice
por: Zheng, Jian, et al.
Publicado: (2020)

Efficacy of GC-376 against SARS-CoV-2 virus infection in the K18 hACE2 transgenic mouse model
por: Cáceres, C. Joaquín, et al.
Publicado: (2021)

Effective protection of ZF2001 against the SARS-CoV-2 Delta variant in lethal K18-hACE2 mice
por: Bian, Lianlian, et al.
Publicado: (2022)

Administration of aerosolized SARS-CoV-2 to K18-hACE2 mice uncouples respiratory infection from fatal neuroinvasion
por: Fumagalli, Valeria, et al.
Publicado: (2021)

NRICM101 ameliorates SARS-CoV-2–S1-induced pulmonary injury in K18-hACE2 mice model
por: Wei, Wen-Chi, et al.
Publicado: (2023)

K18-hACE2 mice develop respiratory disease resembling severe COVID-19
por: Yinda, Claude Kwe, et al.
Publicado: (2020)

K18-hACE2 mice develop respiratory disease resembling severe COVID-19
por: Yinda, Claude Kwe, et al.
Publicado: (2021)

Human convalescent plasma protects K18-hACE2 mice against severe respiratory disease
por: Golden, Joseph W., et al.
Publicado: (2021)

Heterogeneous Infectivity and Pathogenesis of SARS-CoV-2 Variants Beta, Delta and Omicron in Transgenic K18-hACE2 and Wildtype Mice
por: Tarrés-Freixas, Ferran, et al.
Publicado: (2022)

Bacillus Calmette-Guérin–induced trained immunity protects against SARS-CoV-2 challenge in K18-hACE2 mice
por: Zhang, Bao-Zhong, et al.
Publicado: (2022)

Virulence Profiles of Wild-Type, P.1 and Delta SARS-CoV-2 Variants in K18-hACE2 Transgenic Mice
por: da Silva Santos, Yasmin, et al.
Publicado: (2023)

SARS-CoV-2-Specific CD8(+) T-Cells in Blood but Not in the Lungs of Vaccinated K18-hACE2 Mice after Infection
por: Ferrantelli, Flavia, et al.
Publicado: (2023)

Delta (B1.617.2) variant of SARS-CoV-2 induces severe neurotropic patterns in K18-hACE2 mice
por: Yang, Ju-Hee, et al.
Publicado: (2023)

Exploring the disruption of SARS-CoV-2 RBD binding to hACE2
por: Carter, Camryn, et al.
Publicado: (2023)

Mild and Severe SARS-CoV-2 Infection Induces Respiratory and Intestinal Microbiome Changes in the K18-hACE2 Transgenic Mouse Model
por: Seibert, Brittany, et al.
Publicado: (2021)

Microglia do not restrict SARS-CoV-2 replication following infection of the central nervous system of K18-hACE2 transgenic mice
por: Olivarria, Gema M., et al.
Publicado: (2021)

Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 mice
por: Noy-Porat, Tal, et al.
Publicado: (2021)

Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibody
por: Rosenfeld, Ronit, et al.
Publicado: (2021)

RBD-VLP Vaccines Adjuvanted with Alum or SWE Protect K18-hACE2 Mice against SARS-CoV-2 VOC Challenge
por: Wong, Ting Y., et al.
Publicado: (2022)

Matrix Metalloproteinases Expression Is Associated with SARS-CoV-2-Induced Lung Pathology and Extracellular-Matrix Remodeling in K18-hACE2 Mice
por: Gutman, Hila, et al.
Publicado: (2022)

Early pathogenesis profiles across SARS-CoV-2 variants in K18-hACE2 mice revealed differential triggers of lung damages
por: Aw, Zhen Qin, et al.
Publicado: (2022)

Characterization of Three Variants of SARS-CoV-2 In Vivo Shows Host-Dependent Pathogenicity in Hamsters, While Not in K18-hACE2 Mice
por: Toomer, Gabriela, et al.
Publicado: (2022)

DNA immunization with in silico predicted T-cell epitopes protects against lethal SARS-CoV-2 infection in K18-hACE2 mice
por: Persson, Gry, et al.
Publicado: (2023)

Attractive and repulsive residue fragments at the interface of SARS-CoV-2 and hACE2
por: Rodriguez, Jorge H.
Publicado: (2021)

Protective Effects of Astodrimer Sodium 1% Nasal Spray Formulation against SARS-CoV-2 Nasal Challenge in K18-hACE2 Mice
por: Paull, Jeremy R. A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v216terkrtfkk8bcvp7bm2ikpj